4
Changes in Ownership
Viridian Therapeutics, Inc.DE Filed Acc 0000950170-25-093118
Options or other derivatives
- Director acquired 21,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
CAIN CHRISTOPHER W. · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-07-01 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +21,000 | 21,000 | I |
Loading xslF345X05/ownership.xml…